The Medical Letter 3.8.5

The Medical Letter offers critical evaluations of new prescription drugs and comparative reviews of drugs for common conditions in its biweekly newsletter, The Medical Letter on Drugs and Therapeutics. It is a valuable resource that delivers concise, authoritative drug information to healthcare providers, empowering them to make informed treatment choices. With a substantial readership of over a quarter-million subscribers and endorsements from numerous prestigious academic and clinical institutions worldwide, The Medical Letter is recognized as a dependable source for drug-related insights.

Employing a rigorous editorial process, The Medical Letter provides in-depth yet concise analyses of drugs and therapeutics. Grounded in evidence-based research and subjected to peer review, The Medical Letter on Drugs and Therapeutics utilizes expert consensus to assess drugs, assisting healthcare professionals in selecting the most suitable treatment options. Representing an essential reference for impartial and objective drug information, The Medical Letter maintains complete independence from industry influences.

The Medical Letter app offers an extension of the comprehensive content featured in The Medical Letter on Drugs & Therapeutics. Subscribers gain complimentary access to their paid subscription along with the convenience of taking CME/CE exams using their mobile devices. The app delivers unbiased evaluations of newly FDA-approved drugs, comparative reviews of treatments for prevalent conditions like diabetes, hypertension, pain, and insomnia, quick-reference tables, 26 yearly issues spanning back to 1988, and the opportunity to earn up to 52 CME/CE credits annually.

The Medical Letter is an essential tool for healthcare professionals aiming to enhance their practice.